Cochrane Abstracts
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Riluzole for Amyotrophic Lateral Sclerosis (ALS)/motor Neuron Disease (MND)." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433289/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_.
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433289/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_. Accessed January 14, 2026.
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433289/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_
Riluzole for Amyotrophic Lateral Sclerosis (ALS)/motor Neuron Disease (MND) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433289/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
ID - 433289
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433289/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
